Author Correction: Control of tumor-associated macrophages and T cells in glioblastoma via AHR and CD39

Affiliations

• ¹ Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
• ² Divisions of Gastroenterology, Hepatology and Transplantation, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
• ³ Neuroimmunology Research Lab., Center for Excellence in Neuromics, Department of Neuroscience, Université de Montréal, Montréal, Québec, Canada.
• ⁴ Neuroimmunology Unit, Montreal Neurological Institute, Department of Neurology and Neurosurgery, McGill University, Montreal, Québec, Canada.
• ⁵ Dept of Environmental Health, Boston University School of Public Health, Boston, MA, USA.
• ⁶ Center for Research on Neuroimmunological Diseases (CIEN), Raúl Carrea Institute for Neurological Research (FLENI), Buenos Aires, Argentina.
• ⁷ Center for Epidemiology, Biostatistics and Public Health (CEBES), Raúl Carrea Institute for Neurological Research (FLENI), Buenos Aires, Argentina.
• ⁸ Center for Neuro-Oncology, Dana Farber Cancer Institute, Brigham and Women's Hospital, Boston, MA, USA.
• ⁹ The Broad Institute of MIT and Harvard, Cambridge, MA, USA.
• ¹⁰ Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. [email protected].
• ¹¹ The Broad Institute of MIT and Harvard, Cambridge, MA, USA. [email protected].